Patent applications published 27 January 2010
Merck 2146572*
- Bicyclic anilide heterocyclic CGRPreceptor antagonists
Merck 2146572*
- Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists
Portola Pharmaceuticals 2146573*
- Influenza polynucleotides, expression constructs, compsns and methods of use
Alnylam Pharmaceuticals 2146575*
- Treatment of Downs syndrome with benzodiazepine receptor antagonists
Cypress Bioscience; Rao, Srinivas; Anderson, Jeffrey; Kranzler, Jay 2146576*
- Ziprasidone formulations
Scidose 2146577*
- Compsn and methods for cell killing
Opion 2146581*
- Oral cephalotaxine dosage forms
ChenGenex Pharmaceuticals 2146690*
- Nucleic acid microparticles for pulmonary delivery
Baxter International 2146691*
- Proliposomal and liposomal compsns
Fresenius Kabi Oncology 2146692*
- Solifenacin compsns
Dr Reddy's Laboratories Ltd; Dr Reddy's Laboratories Inc 2146693*
- Formulation of active agent loaded activated PLGAnanoparticles for targeted cancer nanotherapeutics
University of North Texas Health Science Center at Fort Worth 2146694*
- Pharmaceutical compsns
Sun Pharmaceutical Industries 2146696*
- Pharmaceutical compsns
Zysis 2146697*
- Rapidly dispersible vaginal tablet that provides a bioadhesive gel
New York Blood Centre 2146698*
- Pharmaceutical compsns comprising oxcarbazepine
Ratiopharm 2146699*
- Protein-modified nano-droplets, compsns and methods of production
The Regents of the University of California 2146700*
- Biodegradable polyanhydrides with natural bioactive molecules
Rutgers, the State University of New Jersey 2146701*
- Method of treating fungal infections
Northeastern University 2146702*
- Method of treating fungal infections
- SRCfamily kinase inhibitors
Leo Pharma 2146703*
- Use of a compsn comprising formoterol and beclometasone dipropionate for the prevention and/or treatment of an exacerbation of asthma
Chiesi Farmaceutici 2146704*
- Combination therapy with a compound acting as a platelet ADPreceptor inhibitor
Portola Pharmaceuticals 2146705*
- Use of dimiracetam in the treatment of chronic pain
Neurotune 2146706*
- Methods and compsns for treating pulmonary hypertension
Abraxis BioScience 2146707*
- Compsn having lipolytic activity, production method thereof and use of the compsn
Nutraceutic et Business Consulting 2146708*
- Iminosugar for the treatment of tumours
University of Oxford 2146709*
- p38alpha as a therapeutic target in bladder cancer
Institut Curie; Centre National de la Recherche Scientifique; Assistance Publique - Hopitaux de Paris; Universite Paris 2146710*- Ischaemia/reperfusion protection compsns and methods of using
Regents of the University of Minnesota 2146711*
- Aryl heterocyclic CGRPreceptor antagonists
Merck 2146712*
- Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)-pyridine-2-carboxamide for the treatment of cranial traumas
Sanofi-Aventis 2146713*
- Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)-N-pyridine-2-carboxamide for the treatment of motor disorders related to Parkinson's disease
Sanofi-Aventis 2146714*
- CGRP receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
Merck 2145715*
- Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
Deciphera Pharmaceuticals 2146716*
- Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
Deciphera Pharmaceuticals 2146717*
- Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
Deciphera Pharmaceuticals 2146718*
- Process for making galantamine
ScinoPharm Taiwan 2146719*
- Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake or norepinephrine, dopamine and serotonin
AMRTechnology; Bristol-Myers Squibb 2146720*
- Methods of using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
Otsuka Pharmaceutical 2146721*
- Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake or norepinephrine, dopamine and serotonin
AMRTechnology; Bristol-Myers Squibb 2146722*
- Means and methods for counteracting protein aggregation
Academisch Ziekenhuis Groningen; Rijkuniversiteit te Groningen 2146723*
- Role of hedgehog signalling in atherosclerosis and cardiovascular disease
The Regent of the University of California 2146724*
- A compsn for regulating cellular senescence comprising N-(2-(cyclohexyloxy)-4-nitrophenyl)-methanesulphonamide
SNUR&DBFoundation 2146725*
- Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions
TAUTherapeutics 2146726*
- High viscosity macromolecular compsns for treating ocular conditions
Allergan 2146727*
- Progenitor cells from urine and methods for using the same
Wake Forest University Health Sciences 2146728*
- New use for cannabinoid-containing plant extracts
GWPharma 2146731*
- Methods of treating or preventing emesis using growth hormone secretagogues
Helsinn Therapeutics 2146732*
- Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
Arch Therapeutics 2146733*
- Novel peptide amphiphiles having improved solubility and methods of using same
Hulvat, James; Gular, Mustafa 2146734*
- Sparc and methods of use thereof
Abraxis Bioscience 2146735*
- Pro- and anti-angiogenic agents
University of Bristol 2146736*
- Copolymer synthesised from modified glycosaminoglycan, GAG, and an anhydride functionalised hydrophobic polymer
Colorado State University Research Foundation 2146737* - Ischaemia/reperfusion protection compsns and methods of using